Veracyte (VCYT) Change in Account Payables (2012 - 2026)

Veracyte has disclosed Change in Account Payables across 15 years of filings, most recently posting $2.6 million for Q1 2026.

• Change in Account Payables for Q1 2026 came in at $2.6 million, down 63.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.6 million (down 227.83% YoY), and the FY2025 annual result was -$1.0 million, up 75.87% from the prior year.
• Change in Account Payables came in at $2.6 million for Q1 2026 at Veracyte, up from -$492000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $7.1 million in Q1 2025 to a low of -$4.0 million in Q2 2025.
• The 5-year median for Change in Account Payables is -$492000.0 (2025), against an average of -$161117.6.
• Peak annual rise in Change in Account Payables reached 561.14% in 2025, while the deepest fall reached 2373.46% in 2025.
• Veracyte's Change in Account Payables stood at $477000.0 in 2022, then tumbled by 166.88% to -$319000.0 in 2023, then plunged by 324.76% to -$1.4 million in 2024, then surged by 63.69% to -$492000.0 in 2025, then jumped by 625.81% to $2.6 million in 2026.
• The last three Change in Account Payables figures came in at $2.6 million (Q1 2026), -$492000.0 (Q4 2025), and -$3.7 million (Q3 2025), per Business Quant data.